ABM HSA Mirna inhibitor

hsa miR miRNA Inhibitor ABM – Antibody-Antibodies

For gene regulation and useful evaluation, abm presents a wide range of expression strategies for:

  1. siRNA: efficiently categorical any purpose siRNA to knockdown any gene with out the necessity to design hair-pin loop shRNA constructions, obtainable in lentivirus, AAV and Adenovirus.
  2. miRNA: inhibit or over-express any miRNA for evaluation of post-transcriptional gene regulation in mammalian strategies utilizing our ready-to-use viral vectors and packaged viruses, together with our detection and quantification gadgets.
  3. UTR Reporters: quantitatively evaluation a selected miRNA’s regulation of its purpose gene utilizing our 3’UTR or 5’UTR platform, all obtainable as a library of premade lentiviral vectors and lentiviruses for any human, mouse or rat gene.

miRNA inhibitors block miRNA regulation of purpose gene expression by protected suppression and should knock down native miRNA expression in cells. They’re typically utilized in miRNA loss-of-function evaluation, miRNA purpose net web page identification and validation, and miRNA screening experiments. abm‘s Lentivirus miRNA Inhibitors permit for protected, long run expression of miRNA inhibitors out of your cell line.

Key Decisions

  • We provide a gaggle of miRNA Inhibitors for knockdown of over 5000 miRNAs from human, mouse, and rat.
  • Lentiviral present for integration of genetic provides into host cells, inflicting protected, long run gene expression.
  • Lentivirus has a broad host differ and should infect each dividing and non-dividing cells, permitting gene present to each sort of cell varieties.
abm hsa mirna inhibitor
abm hsa mirna inhibitor

Background

Non-coding RNAs and considerably microRNAs have been found to behave as grasp regulators of most cancers initiation and enchancment. The intention of our evaluation was to hunt out and characterize the perform of nonetheless functionally uncharacterized microRNAs in human breast carcinogenesis.

Strategies

In an unbiased method, we utilized a longtime mannequin system for breast most cancers (BC) stem cell formation (“mammosphere assay”) to find out full miRNome alterations in breast carcinogenesis. Medical samples of BC victims had been used to judge the human relevance of the newly acknowledged miRNA candidates. One promising candidate, miR-1287-5p, was further explored on its impression on loads of hallmarks of most cancers. The molecular mode of motion was characterised by full transcriptome evaluation, in silico prediction gadgets, miRNA-interaction assays, pheno-copy assays, and drug sensitivity assays.

hsa-let-7b miRNA Inhibitor
MIH01004 2 x 5.0 nmol
EUR 176
hsa-let-7c miRNA Inhibitor
MIH01007 2 x 5.0 nmol
EUR 176
hsa-let-7d miRNA Inhibitor
MIH01010 2 x 5.0 nmol
EUR 176
hsa-let-7e miRNA Inhibitor
MIH01013 2 x 5.0 nmol
EUR 176
hsa-let-7g miRNA Inhibitor
MIH01020 2 x 5.0 nmol
EUR 176
hsa-let-7i miRNA Inhibitor
MIH01023 2 x 5.0 nmol
EUR 176
hsa-miR-1 miRNA Inhibitor
MIH01026 2 x 5.0 nmol
EUR 176
hsa-miR-100 miRNA Inhibitor
MIH01027 2 x 5.0 nmol
EUR 176
hsa-miR-101 miRNA Inhibitor
MIH01030 2 x 5.0 nmol
EUR 176
hsa-miR-103 miRNA Inhibitor
MIH01033 2 x 5.0 nmol
EUR 176
hsa-miR-103b miRNA Inhibitor
MIH01037 2 x 5.0 nmol
EUR 176
hsa-miR-105 miRNA Inhibitor
MIH01038 2 x 5.0 nmol
EUR 176
hsa-miR-106a miRNA Inhibitor
MIH01041 2 x 5.0 nmol
EUR 176
hsa-miR-106b miRNA Inhibitor
MIH01044 2 x 5.0 nmol
EUR 176
hsa-miR-107 miRNA Inhibitor
MIH01047 2 x 5.0 nmol
EUR 176
hsa-miR-10a miRNA Inhibitor
MIH01048 2 x 5.0 nmol
EUR 176
hsa-miR-10b miRNA Inhibitor
MIH01051 2 x 5.0 nmol
EUR 176
hsa-miR-1178 miRNA Inhibitor
MIH01054 2 x 5.0 nmol
EUR 176
hsa-miR-1179 miRNA Inhibitor
MIH01057 2 x 5.0 nmol
EUR 176
hsa-miR-1180 miRNA Inhibitor
MIH01058 2 x 5.0 nmol
EUR 176

Leave a Comment

Your email address will not be published. Required fields are marked *